Literature DB >> 3748583

Adult head and neck soft-tissue sarcomas.

J A Greager, T K Das Gupta.   

Abstract

Adult soft tissue sarcomas of the head and neck are so rare that an accurate diagnosis and appropriate therapy are frequently delayed. A retrospective study of such patients seen at the University of Illinois over the last 15 years has helped to better characterize this disease entity. Patients with sarcoma of the neck, the most common anatomic location (37 per cent), had the highest 5-year disease-free survival rate (67 per cent). Fibrosarcoma was the most common histologic type (25 per cent). Aggressive fibromatosis patients experienced the longest mean survival time (93 months). The disease-free 2-year, 5-year, and 10-year survival rates were found to be 68, 54, and 28 per cent, respectively. Wide excision was the treatment of choice, with adjuvant radiotherapy or chemotherapy, or both, used in selected patients. The sarcomas of all long-term survivors were either well-differentiated or 5.0 cm or less in diameter. It is evident that aggressive therapy of adult head and neck sarcomas can provide good long-term results.

Entities:  

Mesh:

Year:  1986        PMID: 3748583

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

Review 1.  Management of sarcomas of the head and neck.

Authors:  Bruce Brockstein
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

2.  Intraoral neurilemmoma of mental nerve mimicking as traumatic fibroma: An unusual presentation - A case report and literature review.

Authors:  C Ravindran; Pearlcid Siroraj; C Deepak; Malathi Narasimhan
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr

3.  Head and neck sarcomas: prognostic factors and implications for treatment.

Authors:  R A Eeles; C Fisher; R P A'Hern; M Robinson; P Rhys-Evans; J M Henk; D Archer; C L Harmer
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.